Skip to main content

Animations

MJFF Publications

81 - 90 of 8399 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • OPEN
    Title: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulation
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-025-95679-3
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.27248
    Citation Count: 0
  • OPEN
    Title: Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf146
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Phenotyping the Demographic and Behavioral Correlates of Start Hesitation in Parkinson’s Disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107832
    Citation Count: 0
  • OPEN
    Title: Prioritizing Parkinson’s disease risk genes in genome-wide association loci
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00933-0
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci186591
    Citation Count: 0
  • OPEN
    Title: Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
    Journal Name: Fluids and Barriers of the CNS
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s12987-025-00646-9
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaques
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00938-9
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Impact of an inpatient mobility program on outcomes in Parkinson’s disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834
    Citation Count: 0
  • OPEN
    Title: Astrocytic RNA editing regulates the host immune response to alpha-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adp8504
    Best OA location URL:
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.